Edap TMS (EDAP)

4.44 +0.26  +6.22%  May 20, 8:00PM
Add to Watchlists Create an Alert

Edap TMS R&D Expense Quarterly:

0.8917M for Dec. 31, 2012
View Full Chart

Edap TMS R&D Expense Quarterly Chart

    Edap TMS Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 0.8917M
    Sept. 30, 2012 0.5462M
    June 30, 2012 1.064M
    March 31, 2012 0.9426M
    Dec. 31, 2011 0.7657M
    Sept. 30, 2011 0.8975M
    June 30, 2011 0.9275M
    March 31, 2011 0.7564M
    Dec. 31, 2010 0.8927M
    Sept. 30, 2010 0.9391M
    June 30, 2010 1.398M
    March 31, 2010 1.011M
    Dec. 31, 2009 0.9867M
    Sept. 30, 2009 1.407M
    June 30, 2009 1.502M
    March 31, 2009 1.229M
    Dec. 31, 2008 0.8668M
    Sept. 30, 2008 1.457M
    June 30, 2008 1.65M
       
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    EDAP R&D Expense Quarterly Benchmarks

    Companies
    InspireMD 0.907M
    Abiomed 6.822M
    Smith & Nephew 52.00M

    EDAP R&D Expense Quarterly Rankings

    Overall 84th percentile
    1274 of 8002
    Sector 40th percentile
    384 of 650 in Healthcare
    Industry 41st percentile
    53 of 90 in Medical Devices

    EDAP R&D Expense Quarterly Range, Past 5 Years

    Minimum 0.5462M Sep 2012
    Maximum 1.650M Jun 2008
    Average 1.059M